Coinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical Outcomes
- 1 August 2009
- journal article
- review article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (15), 7366-7374
- https://doi.org/10.1128/jvi.00191-09
Abstract
Infection with hepatitis C virus (HCV) is estimated to affect 2% of the world population (90) and is a leading cause of liver-related morbidity and mortality. Human immunodefi- ciency virus (HIV) is also a very important global public health problem, infecting about 33 million people worldwide (129). As the transmission routes are shared by both infections, coin- fection is not uncommon. In this review, we discuss the mag- nitude of the problem, the effect of infection with one virus on the transmission and natural history of the other, and the treatment issues unique to coinfected patients. EPIDEMIOLOGYThis publication has 127 references indexed in Scilit:
- High Prevalence of HIV, HIV/Hepatitis C Virus Coinfection, and Risk Behaviors Among Injection Drug Users in Chennai, India: A Cause for ConcernJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Genetic Divergence of Hepatitis C Virus: The Role of HIV-Related ImmunosuppressionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Human Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis CGastroenterology, 2008
- Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patientsVirus Research, 2007
- Viral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV InfectionGastroenterology, 2007
- Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapyJournal of Hepatology, 2007
- Rapid and early virological response to chronic hepatitis C treatment with IFN 2b or PEG-IFN 2b plus ribavirin in HIV/HCV co-infected patientsGut, 2007
- Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV CoinfectionPLoS Medicine, 2006
- Peginterferon and Ribavirin for Chronic Hepatitis CThe New England Journal of Medicine, 2006
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006